SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-05-004442
Filing Date
2005-08-03
Accepted
2005-08-03 16:12:01
Documents
6
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 IDENIX PHARMACEUTICALS, INC. b55559ipe10vq.htm 10-Q 407118
2 EX- 2005 STOCK INCENTIVE PLAN b55559ipexv10w4.txt EX-10.4 35037
3 EX-31.1 302 CERTIFICATION OF CEO b55559ipexv31w1.htm EX-31.1 7828
4 EX-31.2 302 CERTIFICATION OF CFO b55559ipexv31w2.htm EX-31.2 8292
5 EX-32.1 906 CERTIFICATION OF CEO b55559ipexv32w1.htm EX-32.1 4029
6 EX-32.2 906 CERTIFICATION OF CFO b55559ipexv32w2.htm EX-32.2 3589
  Complete submission text file 0000950135-05-004442.txt   467346
Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET . CAMBRIDGE MA 02139 (617) 250-3100
IDENIX PHARMACEUTICALS INC (Filer) CIK: 0001093649 (see all company filings)

IRS No.: 450478605
Type: 10-Q | Act: 34 | File No.: 000-49839 | Film No.: 05995841
SIC: 2834 Pharmaceutical Preparations